LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

VICTORY CAPITAL MANAGEMENT INC's Holding History (CIK: 0001040188)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 15,148 Value ($000) $8 Avg Close — Range —
Q4 2024
Shares 17,845 Value ($000) $11 Avg Close — Range —
Q3 2024
Shares 14,403 Value ($000) $20 Avg Close — Range —
Q2 2024
Shares 15,296 Value ($000) $22 Avg Close — Range —
Q1 2024
Shares 15,344 Value ($000) $34 Avg Close — Range —
Q4 2023
Shares 16,619 Value ($000) $32 Avg Close — Range —
Q3 2023
Shares 13,242 Value ($000) $19 Avg Close — Range —
Q2 2023
Shares 13,105 Value ($000) $42 Avg Close — Range —
Q1 2023
Shares 13,408 Value ($000) $32 Avg Close — Range —
Q2 2022
Shares 23,167 Value ($000) $151 Avg Close — Range —
Q1 2022
Shares 192,617 Value ($000) $975 Avg Close — Range —
Q4 2021
Shares 206,378 Value ($000) $1,597 Avg Close — Range —
Q3 2021
Shares 209,884 Value ($000) $3,106 Avg Close — Range —
Q2 2021
Shares 192,840 Value ($000) $3,132 Avg Close — Range —